Status:
COMPLETED
Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Recurrent High Grade Gliomas
Eligibility:
All Genders
18+ years
Brief Summary
Brain imaging tests are routinely used to detect the presence of a brain tumor or to evaluate the response to treatment. Sometimes the images obtained are not specific and the only way to establish a ...
Eligibility Criteria
Inclusion
- Histologically proven high grae glioma with central pathology review at DHMC
- Age 18 equal to or greater than 18 years
- Karnofsky performance greater or equal to 60%
- Patients must have received radiation therapy and chemotherapy but should not have received any anti-angiogenesis therapy.
Exclusion
- Any patient who requires urgent surgical resection of MRI abnormality would not be eligible
- Pregnant women are not eligible
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00942760
Start Date
April 1 2009
End Date
April 1 2011
Last Update
May 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756